Access to Biomarker Testing Press Releases
HARRISBURG, PA – FEBRUARY 5, 2024 – With the 2024 legislative session underway and Governor Shapiro’s budget address set for tomorrow, here is a statement from Donna Greco, American Cancer Society Cancer Action Network (ACS CAN) Pennsylvania Government Relations Director:
AUGUSTA, ME – JANUARY 29, 2024 – On Tuesday, January 30, Maine’s Joint Standing Committee on Health Coverage, Insurance and Financial Services will consider LD 1577.
Indiana Must Do Better to Reduce the Burden of Cancer
ALBANY, NY – JANUARY 17, 2024 – With her budget address yesterday, the character of Governor Hochul’s 2024 legislative agenda comes into focus, leading advocates to react and highlight opportunities to reduce the cancer burden in New York in 2024.
CHARLESTON, W. Va. –Delegate Steve Westfall recently introduced legislation that would increase access to biomarker testing, which can help determine the best treatment plan for a specific patient.
TRENTON, NJ – JANUARY 12, 2024 – As lawmakers dive into the 2024 legislative session, the American Cancer Society Cancer Action Network (ACS CAN) urges legislators to prioritize passing legislation to ease the burden of cancer on New Jerseyans, securing each resident equal opport
DES MOINES, Iowa - Statement from Jackie Cale, American Cancer Society Cancer Action Network (ACS CAN) Iowa government relations director:
As lawmakers dive into the 2024 legislative session, the American Cancer Society Cancer Action Network (ACS CAN) urges legislators to prioritize passing legislation to ease the burden of cancer on Hoosiers.
As lawmakers dive into the 2024 legislative session, the American Cancer Society Cancer Action Network (ACS CAN) urges legislators to prioritize passing legislation to ease the burden of cancer on Buckeyes.
As Washington legislators convene for the new session, it is crucial for them to prioritize cancer patients and cancer care by assuring all residents have ready access to biomarker testing.